Alkermes Plc at Cantor Fitzgerald Global Healthcare Conference Transcript
It's been around for a while, and I've admired for a long time. However, I only recently had an opportunity to pick up coverage of Alkermes, and I'm excited to do so. Frankly, I think that this is long been a neuro innovator that has been overlooked and it is becoming increasingly a more -- a company more focused on neuro innovation and developing a pipeline drugs -- pipeline of drugs meant to treat a range of neurological and psychiatric disorders. And in addition, it has a strong commercial base. So with me today is Blair Jackson, the company's Chief Operating Officer. Blair, welcome. Good to see you.
Nice to see you as well.
Questions & Answers
Thanks for joining. I think Blair we'll start probably with an overview and -- I like your socks, I'm a cyclist as well. And then we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |